Gilead – MPP – Arene Lifesciences, HIV Therapeutic License Agreement

• Post author:GHIAA Admin
• Post published:September 28, 2022
• Post category:

Continue ReadingGilead – MPP – Arene Lifesciences, HIV Therapeutic License Agreement

Alnylam Pharmaceuticals – University of British Columbia- AlCana Technology, Sponsored Research Agreement

• Post author:GHIAA Admin
• Post published:September 7, 2022
• Post category:

Continue ReadingAlnylam Pharmaceuticals – University of British Columbia- AlCana Technology, Sponsored Research Agreement

CARB-X Research Subaward Agreement

• Post author:GHIAA Admin
• Post published:August 17, 2022
• Post category:

Continue ReadingCARB-X Research Subaward Agreement

Shionogi – GARDP, Cefiderocol License Agreement

• Post author:GHIAA Admin
• Post published:July 8, 2022
• Post category:

Continue ReadingShionogi – GARDP, Cefiderocol License Agreement

NIH – MPP, COVID-19 Patent and Biological Material License Agreement

• Post author:GHIAA Admin
• Post published:June 29, 2022
• Post category:

Continue ReadingNIH – MPP, COVID-19 Patent and Biological Material License Agreement

Entasis – DNDi/GARDP, Gonorrhoea Medication, Collaboration Agreement

• Post author:GHIAA Admin
• Post published:June 8, 2022
• Post category:

Continue ReadingEntasis – DNDi/GARDP, Gonorrhoea Medication, Collaboration Agreement

Boston University Startup Exclusive License Template

• Post author:GHIAA Admin
• Post published:June 7, 2022
• Post category:

Continue ReadingBoston University Startup Exclusive License Template

Gates Foundation – CureVac, Global Access Commitments Agreement

• Post author:GHIAA Admin
• Post published:June 2, 2022
• Post category:

Continue ReadingGates Foundation – CureVac, Global Access Commitments Agreement

Elkurt – Ocean Biomedical, Malaria Vaccine, Exclusive License Agreement

• Post author:GHIAA Admin
• Post published:May 31, 2022
• Post category:

Continue ReadingElkurt – Ocean Biomedical, Malaria Vaccine, Exclusive License Agreement